NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

Mary B. Daly, Robert Pilarski, Michael P. Berry, +24

Journal of the National Comprehensive Cancer Network

Family MedicineGenetic TestingBreast OncologyReproductive HealthGenetic Epidemiology +22

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Theodore W. Laetsch, Shannon L. Maude, Susana Rives, +23

Journal of Clinical Oncology

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

Daniele Accapezzato, Vittorio Francavilla, Marino Paroli, +6

Journal of Clinical Investigation

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi, +29

The Lancet

InflammationDouble-blind Phase 3Week 16Week 52Medicine +3

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

Kenneth R. Chapman, John R. Hurst, Stefan Frent, +9

American Journal of Respiratory and Critical Care Medicine

Age- and Tumor Subtype–Specific Breast Cancer Risk Estimates for <i>CH</i><i>EK</i><i>2</i>*1100delC Carriers

Marjanka K. Schmidt, Frans B.L. Hogervorst, Richard van Hien, +78

Journal of Clinical Oncology

Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19

Roberto Caricchio, Antonio Abbate, Jamie Meng, +12

JAMA

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

Amir Sonnenblick, Dominique Agbor‐Tarh, Ian Bradbury, +17

Journal of Clinical Oncology

Diabetes ManagementBreast OncologyMedicineCancer ManagementDiabetes +11

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

James C. Yao, Katherine A. Guthrie, César A. Moran, +11

Journal of Clinical Oncology

ImmunologyPathologyPharmacotherapyIfn ArmEndocrine Oncology +14

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells

Andreas Wack, Elisabetta Soldaini, Chien‐Te K. Tseng, +3

European Journal of Immunology